These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 20076843

  • 21. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.
    Ridker PM, Goldhaber SZ, Danielson E, Rosenberg Y, Eby CS, Deitcher SR, Cushman M, Moll S, Kessler CM, Elliott CG, Paulson R, Wong T, Bauer KA, Schwartz BA, Miletich JP, Bounameaux H, Glynn RJ, PREVENT Investigators.
    N Engl J Med; 2003 Apr 10; 348(15):1425-34. PubMed ID: 12601075
    [Abstract] [Full Text] [Related]

  • 22. Low-intensity oral anticoagulant plus low-dose aspirin during the first six months versus standard-intensity oral anticoagulant therapy after mechanical heart valve replacement: a pilot study of low-intensity warfarin and aspirin in cardiac prostheses (LIWACAP).
    Pengo V, Palareti G, Cucchini U, Molinatti M, Del Bono R, Baudo F, Ghirarduzzi A, Pegoraro C, Iliceto S, participating centers of Italian Federation of Anticoagulation Clinics (FCSA).
    Clin Appl Thromb Hemost; 2007 Jul 10; 13(3):241-8. PubMed ID: 17636186
    [Abstract] [Full Text] [Related]

  • 23. Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators.
    Arch Intern Med; 1996 Feb 26; 156(4):409-16. PubMed ID: 8607726
    [Abstract] [Full Text] [Related]

  • 24. Risks of oral anticoagulant therapy with increasing age.
    Torn M, Bollen WL, van der Meer FJ, van der Wall EE, Rosendaal FR.
    Arch Intern Med; 2005 Jul 11; 165(13):1527-32. PubMed ID: 16009869
    [Abstract] [Full Text] [Related]

  • 25. Stroke risk in atrial fibrillation patients on warfarin. Predictive ability of risk stratification schemes for primary and secondary prevention.
    Poli D, Antonucci E, Grifoni E, Abbate R, Gensini GF, Prisco D.
    Thromb Haemost; 2009 Feb 11; 101(2):367-72. PubMed ID: 19190823
    [Abstract] [Full Text] [Related]

  • 26. Effect of heart failure exacerbations on anticoagulation: a prospective, observational, pilot cohort study.
    Ripley TL, Harrison D, Germany RE, Adamson PB.
    Clin Ther; 2010 Mar 11; 32(3):506-14. PubMed ID: 20399987
    [Abstract] [Full Text] [Related]

  • 27. Long-term PT-INR levels and the clinical events in the patients with non-valvular atrial fibrillation: a special reference to low-intensity warfarin therapy.
    Takarada K, Sato M, Goto M, Saito A, Ikeda Y, Fujita S, Fuse K, Takahashi M, Oguro T, Matsushita H, Kitazawa H, Okabe M, Abe H, Toba K, Yamashina A, Aizawa Y.
    J Cardiol; 2014 Aug 11; 64(2):127-32. PubMed ID: 24440439
    [Abstract] [Full Text] [Related]

  • 28. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
    Flaker GC, Gruber M, Connolly SJ, Goldman S, Chaparro S, Vahanian A, Halinen MO, Horrow J, Halperin JL, SPORTIF Investigators.
    Am Heart J; 2006 Nov 11; 152(5):967-73. PubMed ID: 17070169
    [Abstract] [Full Text] [Related]

  • 29. The quality of anticoagulation on functional outcome and mortality for TIA/stroke in atrial fibrillation patients.
    Poli D, Antonucci E, Marcucci R, Mannini L, Falciani M, Abbate R, Gensini GF, Prisco D.
    Int J Cardiol; 2009 Feb 06; 132(1):109-13. PubMed ID: 18180057
    [Abstract] [Full Text] [Related]

  • 30. Anticoagulation for valvular heart disease in community-based practice.
    Rose AJ, Ozonoff A, Henault LE, Hylek EM.
    Thromb Haemost; 2010 Feb 06; 103(2):329-37. PubMed ID: 20024499
    [Abstract] [Full Text] [Related]

  • 31. Low rate of bleeding and thrombotic complications of oral anticoagulant therapy independent of age in the real-practice of an anticoagulation clinic.
    Poli D, Antonucci E, Lombardi A, Boddi V, Gensini GF, Abbate R, Prisco D.
    Blood Coagul Fibrinolysis; 2003 Apr 06; 14(3):269-75. PubMed ID: 12695750
    [Abstract] [Full Text] [Related]

  • 32. Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin: assessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleeding.
    Douketis JD, Arneklev K, Goldhaber SZ, Spandorfer J, Halperin F, Horrow J.
    Arch Intern Med; 2006 Apr 24; 166(8):853-9. PubMed ID: 16636210
    [Abstract] [Full Text] [Related]

  • 33. Efficacy of anticoagulation for secondary stroke prevention in older people with non-valvular atrial fibrillation: a prospective case series study.
    Tsivgoulis G, Spengos K, Zakopoulos N, Manios E, Peppes V, Vemmos K.
    Age Ageing; 2005 Jan 24; 34(1):35-40. PubMed ID: 15591481
    [Abstract] [Full Text] [Related]

  • 34. Low-intensity anticoagulation for stroke prevention in elderly patients with atrial fibrillation: efficacy and safety in actual clinical practice.
    Ono A, Fujita T.
    J Clin Neurosci; 2005 Nov 24; 12(8):891-4. PubMed ID: 16271478
    [Abstract] [Full Text] [Related]

  • 35. Lowering the intensity of oral anticoagulant therapy: effects on the risk of hemorrhage and thromboembolism.
    Torn M, van der Meer FJ, Rosendaal FR.
    Arch Intern Med; 2004 Mar 22; 164(6):668-73. PubMed ID: 15037497
    [Abstract] [Full Text] [Related]

  • 36. Clinical outcome in Japanese elderly patients with non-valvular atrial fibrillation taking warfarin: a single-center observational study.
    Naganuma M, Shiga T, Sato K, Murasaki K, Hashiguchi M, Mochizuki M, Hagiwara N.
    Thromb Res; 2012 Jul 22; 130(1):21-6. PubMed ID: 22137743
    [Abstract] [Full Text] [Related]

  • 37. Anticoagulation therapy in Chinese patients with non-valvular atrial fibrillation: a prospective, multi-center, randomized, controlled study.
    Chen KP, Huang CX, Huang DJ, Cao KJ, Ma CS, Wang FZ, Zhang S.
    Chin Med J (Engl); 2012 Dec 22; 125(24):4355-60. PubMed ID: 23253701
    [Abstract] [Full Text] [Related]

  • 38. Evaluation of the pattern of treatment, level of anticoagulation control, and outcome of treatment with warfarin in patients with non-valvar atrial fibrillation: a record linkage study in a large British population.
    Jones M, McEwan P, Morgan CL, Peters JR, Goodfellow J, Currie CJ.
    Heart; 2005 Apr 22; 91(4):472-7. PubMed ID: 15772203
    [Abstract] [Full Text] [Related]

  • 39. Intensity of anticoagulation with warfarin and risk of adverse events in patients presenting to the emergency department.
    Anthony CJ, Karim S, Ackroyd-Stolarz S, Fry A, Murphy NG, Christie R, Zed PJ.
    Ann Pharmacother; 2011 Jul 22; 45(7-8):881-7. PubMed ID: 21750309
    [Abstract] [Full Text] [Related]

  • 40. Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial.
    Eikelboom JW, Wallentin L, Connolly SJ, Ezekowitz M, Healey JS, Oldgren J, Yang S, Alings M, Kaatz S, Hohnloser SH, Diener HC, Franzosi MG, Huber K, Reilly P, Varrone J, Yusuf S.
    Circulation; 2011 May 31; 123(21):2363-72. PubMed ID: 21576658
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.